Canada Pension Plan Investment Board’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
Canada Pension Plan Investment Board's AZN Position: Q2 2026 in Review
Canada Pension Plan Investment Board increased its AstraZeneca (AZN) stake by 104% in Q2 2026, buying an estimated $129M and bringing the position to 1,347,313 shares worth $253M. The position accounts for 0.14% of the portfolio, ranked #149.
Canada Pension Plan Investment Board first reported a position in AZN in Q2 2013 and has held it in 18 quarters since. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Canada Pension Plan Investment Board held 1,347,313 shares of AstraZeneca worth $253M as of Q2 2026.
- Canada Pension Plan Investment Board bought 685,768 AstraZeneca shares in Q2 2026, an estimated $129M.
- AstraZeneca made up 0.14% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #149 holding.
- Canada Pension Plan Investment Board first reported a position in AstraZeneca in Q2 2013 and has held it in 18 quarters since.
- 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.